Technology | June 11, 2014

FDA Clears VuCOMP M-Vu Computer-Aided Detection for Mammography Version 3.1

June 11, 2014 — VuCOMP Inc. announced it has received U.S. Food and Drug Administration (FDA) approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD (computer-aided detection) station, which includes the ability to process additional standard screening views. Together, the CAD system updates provide radiologists with faster processing time, enhanced workflow and improved parallel architecture.

Jim Pike, president and CTO of VuCOMP, said, “We are committed to the continuous improvement of our product line, and each new release of M-Vu CAD offers advances that provide substantial value to the system and our customers. These latest updates are no exception.”

The M-Vu CAD system uses advanced computer vision algorithms to identify areas of a mammogram that are consistent with breast cancer. M-Vu CAD version 1 was the first product to meet the FDA-recommended reader study standard for proving the effectiveness of mammography CAD. VuCOMP continues to provide systematic product updates, fulfilling the company’s commitment to ongoing enhancements for its customers at no additional cost.

M-Vu CAD is approved for digital mammography systems manufactured by Carestream, Fuji, GE, Giotto, Hologic, Konica Minolta, Philips, Planmed and Siemens. For clinics having a variety of digital mammography systems, M-Vu can now provide a unified solution.

In addition to M-Vu CAD, VuCOMP has developed and commercialized a M-Vu Breast Density solution that received FDA market clearance in December 2013.

For more information: www.vucomp.com

Related Content

Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
DenseBreast-info.org Launches European-Focused Education Coalition
News | Breast Density | February 19, 2018
DenseBreast-info.org (DB-I) announced plans for international expansion with specialized content for Europe and...
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
An example of opto-acoustic breast imaging using the Seno system.

An example of opto-acoustic breast imaging using the Seno system.  

Feature | RSNA 2017 | January 29, 2018
January 26, 2017 — There were three high-impact clinical trials presented at the 2017 Radiological Society of North A
What It Takes to Remain an MQSA-Qualified Inspector
Feature | Mammography | January 26, 2018
The U.S. Food and Drug Administration (FDA) published a new Insight Article detailing the oversight process for the...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Overlay Init